Vietnam: Ban from Ministry of Health vs. Piloting Management from Ministry of Industry and Commerce

Regulations by 2FIRSTS, edited by Sophia
May.05.2024
Vietnam: Ban from Ministry of Health vs. Piloting Management from Ministry of Industry and Commerce
Vietnam debates whether to ban or regulate e-cigarettes due to potential health risks and widespread use among youth.

According to Vietnamese media outlet Viettimes, on May 4th, the issue of whether to ban or regulate e-cigarettes was discussed in the National Assembly by the Social Affairs Committee and the National Assembly's Committee on Cultural Education to address concerns about the harm caused by e-cigarettes and heated tobacco products.

 

Deputy Minister of Health Dao Honglan stated that the Ministry of Health has already done a lot of work, providing advice to the national management through evidence and impact assessment in order to revise the Tobacco Harmful Effects Law and make plans. Minister of Industry and Trade Pan Sheng proposed piloting management of e-cigarettes.

 

Faced with the conflicting views of the Ministry of Health and the Ministry of Industry and Commerce on e-cigarettes, representatives in Congress raised pointed questions.

 

The Vice Chairman of the Vietnamese National Assembly, Tran Thanh Man, expressed concerns about the increasing prevalence of e-cigarette use, especially among young people, teenagers, and students, which are gradually replacing traditional tobacco. He emphasized that the health risks of e-cigarettes are similar to traditional tobacco, particularly the harm they pose to the brain development of children and adolescents, leading to addiction, cognitive and emotional disorders, reduced learning abilities, and psychological obstacles. E-cigarettes also have a negative impact on the quality of human resources, affecting social order and economic and social development.

 

Vice Chairperson of the Cultural and Education Committee, Ms. Ruan Mei, calls for clarity on the boundaries between the economic benefits of e-cigarettes and the negative impacts on health costs.

 

Speaking at the conference, Dr. Nguyen Vinh Chi firmly stated, "I find it strange, why test addictive substances, especially such deadly substances. There is absolutely no need for any testing! Because e-cigarettes have already proliferated globally and in Vietnam, their harm is widely recognized... As a doctor, I question whether anyone can find any benefits of this e-cigarette!"

 

Dao Honglan emphasized that e-cigarettes and heated tobacco products pose great risks to human health, and therefore should be banned from the start rather than being allowed on the market before becoming unmanageable. Even with the various current methods of e-cigarette regulation, the question of whether they can be effectively managed is a concerning issue. Who will be responsible for people's lives? Especially when around 40,000 people die from smoking each year.

 

Deputy Director Chen Ruanquan, of the Legal and Administrative Reform Department of the Ministry of Public Security, shares the same view as the Ministry of Health, believing that e-cigarettes pose a harm to human health, particularly for young people. He maintains that this product not only harms human health but also the economy. In particular, individuals who have been convicted of drug offenses are increasingly using e-cigarettes to soak and mix drugs.

 

Teenage use of e-cigarettes is widespread. People are always seen using e-cigarettes while waiting at red lights on the streets. This trend is growing at a concerning rate, so the harms of e-cigarettes outweigh the expected economic and social benefits, according to Rear Admiral Chen Ruanquan.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Reynolds Puts Nearly 183,000 U.S. Contracted Outlets Under Age-Verification Rules, Covering 94% of Volume — Can It Shift an Unauthorized Vape Market?
Reynolds Puts Nearly 183,000 U.S. Contracted Outlets Under Age-Verification Rules, Covering 94% of Volume — Can It Shift an Unauthorized Vape Market?
Reynolds American says nearly 183,000 U.S. retail outlets are under contract, with its Retail Marketing Plan Contract covering about 94% of company volume and requiring point-of-sale age verification. The company combines those contracts with We Card, TruAge, NACS-linked infrastructure and POS integration, while enhanced Vuse Pro retail rules add ID scanning, purchase limits and stronger underage-sales accountability. The initial Vuse Pro rollout targets about 50,000 stores. The system is taking shape as unauthorized vapor products remain dominant in parts of the U.S. market: a 2026 study estimated they accounted for 69.4% of tracked brick-and-mortar e-cigarette dollar sales in December 2025.
Special Report
Oct.15
Reynolds Showcases Vuse Pro Flavors and VELO Nicotine Pouches at NACS Show 2026
Reynolds Showcases Vuse Pro Flavors and VELO Nicotine Pouches at NACS Show 2026
Reynolds American, a BAT subsidiary, showcased four Vuse Pro flavored e-cigarette pods and its VELO nicotine pouch portfolio at NACS Show 2026. Booth staff confirmed to 2Firsts that the Vuse Pro flavors are sold in the U.S., although they have not received FDA marketing authorization. BAT outlined plans to expand Vuse retail distribution and reported that VELO held a 30.5% year-to-date volume share of the U.S. modern oral nicotine category through August 2026. The booth also featured the newly launched VELO MAX range and merchandising displays combining cigarettes, vaping products and oral nicotine brands.
EXPO
Oct.09
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Holdings said in its latest shareholder letter that it is moving to commercialize PACHA products and monetize its PMTA assets as the FDA changes enforcement priorities for unauthorized ENDS products. Thirty PACHA SKUs were previously tentatively identified for a proposed public list of products that the FDA generally does not intend to prioritize for enforcement. Charlie’s is also preparing test-market sales of age-gated flavored disposables and says it currently holds 678 PMTA-related product assets while seeking additional strategic transactions and partnerships.
Sep.11
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation Limited has been granted a Chinese invention patent covering 6-methylnicotine salt formulations and their use in oral and vaping products. The technology forms salts between 6-methylnicotine and alicyclic carboxylic acids, with granted claims extending to oral products, atomization substrates and electronic atomization devices. Applicant-generated tests reported differences in oxidation stability, in-vitro cytotoxicity and aerosol heavy-metal performance compared with selected benzoate or lactate controls. HG Innovation is directly linked to the broader IMiracle and ELFBAR business network.
Sep.04
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
U.S. Customs and Border Protection ruled that STIIIZY had not shown that the redesigned cannabis-vape products covered by its latest request fall outside an ITC limited exclusion order tied to PAX Labs patents. CBP accepted some of STIIIZY’s claim-construction and non-infringement arguments, but the company did not address two additional claims in the same patent. Earlier STIIIZY redesigned cartridges and certain associated components imported with them had received separate CBP clearance.
Sep.16
Kumulus Vape2026 H1 Revenue Falls 8.3% but Profit Rises 24% as B2B Weakens and Consumer Channels Grow
Kumulus Vape2026 H1 Revenue Falls 8.3% but Profit Rises 24% as B2B Weakens and Consumer Channels Grow
French vaping company Kumulus Vape reported first-half 2026 revenue of €25.5 million, down 8.3% year over year, as its core B2B distribution business fell 11% to €21.6 million. B2C and store-network revenue rose 5.6% and 17.8%, respectively. Commercial margin increased to 26.3% from 21.7%, while net profit rose 24.1% to €0.8 million. The company attributed the profitability improvement to catalog optimization, logistics restructuring and the ramp-up of Labster, its in-house production unit for proprietary brands.
Market
Sep.17 by 2Firsts Perspectives